Market Research Logo

Respiratory Diseases Drugs Market Global Report 2017 Including: Anti-Asthmatics And COPD Drugs Market, Cough And Cold Preparations, Covering: GlaxosmithKline, Novartis AG, Pfizer Inc., Boehringer Ingelheim, and AstraZeneca PLC

Respiratory Diseases Drugs Market Global Report 2017 Including: Anti-Asthmatics And COPD Drugs Market, Cough And Cold Preparations, Covering: GlaxosmithKline, Novartis AG, Pfizer Inc., Boehringer Ingelheim, and AstraZeneca PLC

Top competitors in the respiratory diseases drugs market are strategically partnering and collaborating with other companies to broaden their product portfolio is a major trend in this market. For instance, in March 2017, AstraZeneca announced collaboration with Circassia Pharmaceuticals plc, (a UK based respiratory biopharmaceutical company) for the development and commercialisation of Tudorza and Duaklir in the US. Tudorza and Duaklir are used in the treatment of chronic obstructive pulmonary disease (COPD).

The Respiratory Diseases Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global respiratory diseases drugs sector.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:

Where is the largest and fastest growing market for the respiratory diseases drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The respiratory diseases drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The respiratory diseases drugs market section of the report gives context. It compares the respiratory diseases drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Respiratory Diseases Drugs Indicators Comparison.
  • The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope

Markets Covered: Anti-Asthma And COPD Products Market, Cough And Cold Preparations

Companies Mentioned: GlaxosmithKline, Novartis AG, Pfizer Inc., Boehringer Ingelheim, and AstraZeneca PLC

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Respiratory Diseases Drugs Indicators Comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Respiratory Diseases Drugs Market Characteristics
2. Respiratory Diseases Drugs Market Size And Growth
2.1. Historic Market Growth
2.1.1. Drivers Of The Market
2.1.2. Restraints On The Market
2.2. Forecast Market Growth
2.2.1. Drivers Of The Market
2.2.2. Restraints On The Market
3. Pestle Analysis
3.1. Political
3.2. Economic
3.3. Social
3.4. Technological
3.5. Legal
3.6. Environmental
4. Respiratory Diseases Drugs Market Customer Information
5. Respiratory Diseases Drugs Market Segmentation
5.1. Global Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
5.2. Global Respiratory Diseases Drugs Market, 2012 - 2020, Historic And Forecast, By Segment
5.3 Global Respiratory Diseases Drugs Market Trends And Strategies
6. Respiratory Diseases Drugs Market Regional And Country Analysis
6.1. Global Respiratory Diseases Drugs Market, 2016, By Region
6.2. Global Respiratory Diseases Drugs Market, 2012 - 2020, Historic And Forecast, By Region
6.3. Respiratory Diseases Drugs Market, 2016, By Country
6.4. Respiratory Diseases Drugs Market, 2012 - 2020, Historic And Forecast, By Country
6.5. Global Pharmaceutical Market Segments, 2016, By Region
6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region
6.7. Global Pharmaceutical Market Segments, 2016, By Country
6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country
7. Global Respiratory Diseases Drugs Market Comparison With Macro Economic Factors
7.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, Global
7.2. Per Capita Average Respiratory Diseases Drugs Expenditure, Global
8. Respiratory Diseases Drugs Market Comparison With Macro Economic Factors Across Countries
8.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, By Country
8.2. Per Capita Average Respiratory Diseases Drugs Expenditure, By Country
9. Respiratory Diseases Drugs Market Comparison With Industry Metrics
9.1. Global Number Of Pharmacists, 2016, By Country
9.2. Global Respiratory Diseases Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country
9.3. Global Number Of Pharma Enterprises, 2016, By Country
9.4. Global Respiratory Diseases Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
9.5. Global Average Spending On R&D/Product Development, 2016, By Country
9.6. Global Respiratory Diseases Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country
9.8. Global Respiratory Diseases Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country
9.9. Prevalent Cases Of Asthma, 2014, By Country
9.10. Global Number Of General Practitioners 2016, By Country
9.11. Global Respiratory Diseases Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country
10. Asia-Pacific Respiratory Diseases Drugs Market
10.1.1. Asia-Pacific Respiratory Diseases Drugs Market Overview
10.1.2. Asia-Pacific Respiratory Diseases Drugs Historic Market, 2012 - 2016
10.1.3. Asia-Pacific Respiratory Diseases Drugs Forecast Market, 2016 - 2020
10.1.4. Asia-Pacific Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
10.2. Asia-Pacific Respiratory Diseases Drugs Market: Country Analysis
10.3. China Respiratory Diseases Drugs Market
10.3.1. China Respiratory Diseases Drugs Market Overview
10.3.2. China Respiratory Diseases Drugs Historic Market, 2012 - 2016
10.3.3. China Respiratory Diseases Drugs Forecast Market, 2016 - 2020
10.3.4. China Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
10.3.5. China Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
10.3.6. China Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
10.4. India Respiratory Diseases Drugs Market
10.4.1. India Respiratory Diseases Drugs Market Overview
10.4.2. India Respiratory Diseases Drugs Historic Market, 2012 - 2016
10.4.3. India Respiratory Diseases Drugs Forecast Market, 2016 - 2020
10.4.4. India Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
10.4.5. India Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
10.4.6. India Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
10.5. Japan Respiratory Diseases Drugs Market
10.5.1. Japan Respiratory Diseases Drugs Market Overview
10.5.2. Japan Respiratory Diseases Drugs Historic Market, 2012 - 2016
10.5.3. Japan Respiratory Diseases Drugs Forecast Market, 2016 - 2020
10.5.4. Japan Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
10.5.5. Japan Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
10.5.6. Japan Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
10.6. Australia Respiratory Diseases Drugs Market
10.6.1. Australia Respiratory Diseases Drugs Historic Market, 2012 - 2016
10.6.2. Australia Respiratory Diseases Drugs Forecast Market, 2016 - 2020
10.6.3. Australia Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
10.6.4. Australia Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
10.6.5. Australia Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
11. Western Europe Respiratory Diseases Drugs Market
11.1.1. Western Europe Respiratory Diseases Drugs Market Overview
11.1.2. Western Europe Respiratory Diseases Drugs Historic Market, 2012 - 2016
11.1.3. Western Europe Respiratory Diseases Drugs Forecast Market, 2016 - 2020
11.1.4. Western Europe Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
11.2. Western Europe Respiratory Diseases Drugs Market: Country Analysis
11.3. UK Respiratory Diseases Drugs Market
11.3.1. UK Respiratory Diseases Drugs Market Overview
11.3.2. UK Respiratory Diseases Drugs Historic Market, 2012 - 2016
11.3.3. UK Respiratory Diseases Drugs Forecast Market, 2016 - 2020
11.3.4. UK Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
11.3.5. UK Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
11.3.6. UK Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
11.4. Germany Respiratory Diseases Drugs Market
11.4.1. Germany Respiratory Diseases Drugs Historic Market, 2012 - 2016
11.4.2. Germany Respiratory Diseases Drugs Forecast Market, 2016 - 2020
11.4.3. Germany Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
11.4.4 Germany Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
11.4.5 Germany Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
11.5 France Respiratory Diseases Drugs Market
11.5.1 France Respiratory Diseases Drugs Historic Market, 2012 - 2016
11.5.2 France Respiratory Diseases Drugs Forecast Market, 2016 - 2020
11.5.3 France Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
11.5.4 France Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
11.5.5 France Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
11.6. Italy Respiratory Diseases Drugs Market
11.6.1. Italy Respiratory Diseases Drugs Historic Market, 2012 - 2016
11.6.2. Italy Respiratory Diseases Drugs Forecast Market, 2016 - 2020
11.6.3. Italy Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
11.6.4. Italy Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
11.6.5. Italy Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
11.7. Spain Respiratory Diseases Drugs Market
11.7.1. Spain Respiratory Diseases Drugs Historic Market, 2012 - 2016
11.7.2. Spain Respiratory Diseases Drugs Forecast Market, 2016 - 2020
11.7.3. Spain Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
11.7.4. Spain Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
11.7.5. Spain Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
12. Eastern Europe Respiratory Diseases Drugs Market
12.1.1. Eastern Europe Respiratory Diseases Drugs Market Overview
12.1.2. Eastern Europe Respiratory Diseases Drugs Historic Market, 2012 - 2016
12.1.3. Eastern Europe Respiratory Diseases Drugs Forecast Market, 2016 - 2020
12.1.4 Eastern Europe Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
12.2. Eastern Europe Respiratory Diseases Drugs Market: Country Analysis
12.3. Russia Respiratory Diseases Drugs Market
12.3.1. Russia Respiratory Diseases Drugs Historic Market, 2012 - 2016
12.3.2. Russia Respiratory Diseases Drugs Forecast Market, 2016 - 2020
12.3.3. Russia Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
12.3.4. Russia Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
12.3.5. Russia Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
13. North America Respiratory Diseases Drugs Market
13.1.1. North America Respiratory Diseases Drugs Market Overview
13.1.2. North America Respiratory Diseases Drugs Historic Market, 2012 - 2016
13.1.3. North America Respiratory Diseases Drugs Forecast Market, 2016 - 2020
13.1.4. North America Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
13.2. North America Respiratory Diseases Drugs Market: Country Analysis
13.3. USA Respiratory Diseases Drugs Market
13.3.1. USA Respiratory Diseases Drugs Historic Market, 2012 - 2016
13.3.2. USA Respiratory Diseases Drugs Forecast Market, 2016 - 2020
13.3.3 USA Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
13.3.4. USA Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
13.3.5. USA Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
14. South America Respiratory Diseases Drugs Market
14.1.1. South America Respiratory Diseases Drugs Market Overview
14.1.2. South America Respiratory Diseases Drugs Historic Market, 2012 - 2016
14.1.3. South America Respiratory Diseases Drugs Forecast Market, 2016 - 2020
14.1.4. South America Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
14.2. South America Respiratory Diseases Drugs Market: Country Analysis
14.3. Brazil Respiratory Diseases Drugs Market
14.3.1. Brazil Respiratory Diseases Drugs Historic Market, 2012 - 2016
14.3.2. Brazil Respiratory Diseases Drugs Forecast Market, 2016 - 2020
14.3.3. Brazil Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
14.3.4. Brazil Respiratory Diseases Drugs Percentage Of GDP, 2012 - 2020
14.3.5. Brazil Per Capita Average Respiratory Diseases Drugs Expenditure, 2012 - 2020
15. Middle East Respiratory Diseases Drugs Market
15.1.1. Middle East Respiratory Diseases Drugs Market Overview
15.1.2. Middle East Respiratory Diseases Drugs Historic Market, 2012 - 2016
15.1.3. Middle East Respiratory Diseases Drugs Forecast Market, 2016 - 2020
15.1.4. Middle East Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
16. Africa Respiratory Diseases Drugs Market
16.1.1. Africa Respiratory Diseases Drugs Market Overview
16.1.2. Africa Respiratory Diseases Drugs Historic Market, 2012 - 2016
16.1.2. Africa Respiratory Diseases Drugs Historic Market, 2012 - 2016
16.1.3. Africa Respiratory Diseases Drugs Forecast Market, 2016 - 2020
16.1.4. Africa Respiratory Diseases Drugs Market, 2016, By Segment
Anti-Asthmatics And COPD Drugs Market
Cough And Cold Preparations
17. Respiratory Diseases Drugs Market Competitive Landscape
17.1. Company Profiles
17.2. GlaxoSmithKline
17.2.1. Overview
17.2.2. Products And Services
17.2.3. Strategy
17.2.4. Financial Performance
17.3. Novartis Ag
17.3.1. Overview
17.3.2. Products And Services
17.3.3. Strategy
17.3.4. Financial Performance
17.4. Pfizer Inc.
17.4.1. Overview
17.4.2. Products And Services
17.4.3. Strategy
17.4.4. Financial Performance
17.5. Boehringer Ingelheim
17.5.1. Overview
17.5.2. Products And Services
17.5.3. Strategy
17.5.4. Financial Performance
17.6. Astrazeneca Plc
17.6.1. Overview
17.6.2. Products And Services
17.6.3. Strategy
17.6.4. Financial Performance
18. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market
19. Market Background: Pharmaceutical Drugs Market
19.1.1. Pharmaceutical Drugs Market Characteristics
19.1.2. Pharmaceutical Drugs Market Historic Growth
19.1.2.1. Drivers Of The Market
19.1.2.2. Restraints Of The Market
19.1.3. Pharmaceutical Drugs Market Forecast Growth
19.1.3.1. Drivers Of The Market
19.1.3.2. Restraints Of The Market
19.1.4. Pharmaceutical Drugs Trends And Strategies
19.2. Pharmaceutical Drugs Market Regional And Country Analysis
19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region
19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region
19.2.3. Pharmaceutical Drugs Market, 2016, By Country
19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country
19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment
19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment
19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors
19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global
19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global
19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries
19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country
19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country
19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
21.1. NAICS Definitions Of Industry Covered In This Report
21.2. Abbreviations
21.3. Currencies
21.4. Research Inquiries
21.5. The Business Research Company
21.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report